SummaryWe examined the leukemic stem cell potential of blasts at different stages of maturation in childhood acute lymphoblastic leukemia (ALL). Human leukemic bone marrow was transplanted intrafemorally into NOD/scid mice. Cells sorted using the B precursor differentiation markers CD19, CD20, and CD34 were isolated from patient samples and engrafted mice before serial transplantation into primary or subsequent (up to quaternary) recipients. Surprisingly, blasts representative of all of the different maturational stages were able to reconstitute and reestablish the complete leukemic phenotype in vivo. Sorted blast populations mirrored normal B precursor cells with transcription of a number of stage-appropriate genes. These observations info...
An 18-month-old girl was diagnosed with prepre-B ALL/t(4;11) leukemia, which during thetreatment and...
SummaryUsing a mouse model of human acute myeloid leukemia (AML) induced by the MLL-AF9 oncogene, we...
Acute lymphoblastic leukemia (ALL) is the most common malignancy in pediatric patients. About 10–15%...
SummaryWe examined the leukemic stem cell potential of blasts at different stages of maturation in c...
We examined the leukemic stem cell potential of blasts at different stages of maturation in childhoo...
We examined the leukemic stem cell potential of blasts at different stages of maturation in childhoo...
We have recently shown that in childhood acute lymphoblastic leukemia (ALL) blasts at different stag...
Phd ThesisFor many cancers research led to controversial results regarding frequency and identity of...
Pediatric acute lymphoblastic leukemia (ALL) is a heterogeneous disease, caused by the malignant tra...
Despite enormous improvements in pre-clinical and clinical research, acute leukemia still represents...
For children with an early bone marrow relapse or relapsed T-cell acute lymphoblastic leukemia (ALL)...
The blood-related cancer leukemia was the first disease where human cancer stem cells (CSCs), or leu...
High frequencies of blasts in primary acute lymphoblastic leukaemia (ALL) samples have the potential...
We studied 57 childhood acute lymphoblastic leukaemia (ALL) patients who remained in continuous comp...
Childhood acute lymphoblastic leukaemia (cALL) is distinct from that in adults with higher incidence...
An 18-month-old girl was diagnosed with prepre-B ALL/t(4;11) leukemia, which during thetreatment and...
SummaryUsing a mouse model of human acute myeloid leukemia (AML) induced by the MLL-AF9 oncogene, we...
Acute lymphoblastic leukemia (ALL) is the most common malignancy in pediatric patients. About 10–15%...
SummaryWe examined the leukemic stem cell potential of blasts at different stages of maturation in c...
We examined the leukemic stem cell potential of blasts at different stages of maturation in childhoo...
We examined the leukemic stem cell potential of blasts at different stages of maturation in childhoo...
We have recently shown that in childhood acute lymphoblastic leukemia (ALL) blasts at different stag...
Phd ThesisFor many cancers research led to controversial results regarding frequency and identity of...
Pediatric acute lymphoblastic leukemia (ALL) is a heterogeneous disease, caused by the malignant tra...
Despite enormous improvements in pre-clinical and clinical research, acute leukemia still represents...
For children with an early bone marrow relapse or relapsed T-cell acute lymphoblastic leukemia (ALL)...
The blood-related cancer leukemia was the first disease where human cancer stem cells (CSCs), or leu...
High frequencies of blasts in primary acute lymphoblastic leukaemia (ALL) samples have the potential...
We studied 57 childhood acute lymphoblastic leukaemia (ALL) patients who remained in continuous comp...
Childhood acute lymphoblastic leukaemia (cALL) is distinct from that in adults with higher incidence...
An 18-month-old girl was diagnosed with prepre-B ALL/t(4;11) leukemia, which during thetreatment and...
SummaryUsing a mouse model of human acute myeloid leukemia (AML) induced by the MLL-AF9 oncogene, we...
Acute lymphoblastic leukemia (ALL) is the most common malignancy in pediatric patients. About 10–15%...